Miltefosine in the treatment of cutaneous leishmaniasis caused by Leishmania braziliensis in Brazil: a randomized and controlled trial.

• Main Authors: Paulo R Machado (Author), Julia Ampuero (Author), Luiz H Guimarães (Author), Leonardo Villasboas (Author), Ana T Rocha (Author), Albert Schriefer (Author), Rosana S Sousa (Author), Anette Talhari (Author), Gerson Penna (Author), Edgar M Carvalho (Author)
• Format: Book
• Published: Public Library of Science (PLoS), 2010-12-01T00:00:00Z.
• Subjects: article
• Online Access: Connect to this object online.

Cutaneous leishmaniasis (CL) is treated with parenteral drugs for decades with decreasing rate cures. Miltefosine is an oral medication with anti-leishmania activity and may increase the cure rates and improve compliance.This study is a randomized, open-label, controlled clinical trial aimed to eval...